EuroBioForum 2012 | 18 April 2012
Presentation by Jan-Eric Litton, Professor at Department for Medical Epidemiology and Biostatistics, Karolinska Institutet
EuroBioForum 2013 - Day 2 | Pelagiya DragomirovaEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# EARLY BIRD TALK #
The social media & web technology boost - intruder or trigger?
Pelagiya Dragomirova
Communications Advisor at Publimarket
=======================================
http://www.eurobioforum.eu
Dr. Amy Peasland is the Manager of the Newcastle Biomedicine Central Biobank in Newcastle, England. She obtained her BSc in Biological Sciences from the University of Leicester, including a sandwich year studying in Portugal. She went on to complete an MSc in Molecular Pathology and Toxicology and a PhD in molecular biology from Newcastle University. After several years of postdoctoral research, she transitioned to her current role as Biobank Manager, where she oversees the storage, processing, and distribution of human biospecimens for medical research.
The EMBL-European Bioinformatics Institute (EBI) is a large bioinformatics research and services institute located in Hinxton, UK. It is part of the European Molecular Biology Laboratory and houses massive biological databases and bioinformatics software tools that are freely available to researchers. Key goals of EBI include building and maintaining biological databases, making data widely accessible, and conducting bioinformatics research to advance biology. EBI coordinates data collection and dissemination internationally and houses over 500 staff from diverse backgrounds.
European Molecular Biology Laboratory (EMBL)- European Bioinformatics Institu...ExternalEvents
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
Building the Database with International Isolates: European Molecular Biology Laboratory (EMBL)- European Bioinformatics Institute (EBI). Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management -23-25 May 2016, Rome, Italy.
This document provides information about the upcoming Biobanking 2010 conference, including details about speakers, workshops, and topics that will be discussed. Some key points:
- The conference will take place from September 27-29, 2010 in London and will focus on advancing international R&D through effective sample management and global biobanking harmonization.
- There will be 4 pre-conference workshops covering topics like biobanking technologies, optimizing operating efficiency with IT, establishing global biobanking networks, and building internal pharmaceutical biobanks.
- The main conference over 2 days will include sessions on biobanking within pharmaceutical companies, ensuring high sample quality, integrating biobanking into biomarker research, and building
This document discusses databases in bioinformatics. It begins by explaining that bioinformatics concerns the creation and maintenance of biological databases to allow researchers to access existing information and submit new entries. The aims of bioinformatics are to organize data, develop analysis tools, and use these tools to analyze data and interpret results in a biologically meaningful way. Several important biological databases are described, including nucleotide sequence databases like NCBI and protein sequence databases. GenBank is also discussed as the annotated collection of all publicly available DNA sequences. Biological databases make large datasets available to researchers and are important for biological research infrastructure.
British Library Datasets Programme
John Kaye - Lead Content Specialist datasets, British Library spoke on the British Library's Datasets programme and the DataCite project
EuroBioForum 2013 - Day 2 | Pelagiya DragomirovaEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# EARLY BIRD TALK #
The social media & web technology boost - intruder or trigger?
Pelagiya Dragomirova
Communications Advisor at Publimarket
=======================================
http://www.eurobioforum.eu
Dr. Amy Peasland is the Manager of the Newcastle Biomedicine Central Biobank in Newcastle, England. She obtained her BSc in Biological Sciences from the University of Leicester, including a sandwich year studying in Portugal. She went on to complete an MSc in Molecular Pathology and Toxicology and a PhD in molecular biology from Newcastle University. After several years of postdoctoral research, she transitioned to her current role as Biobank Manager, where she oversees the storage, processing, and distribution of human biospecimens for medical research.
The EMBL-European Bioinformatics Institute (EBI) is a large bioinformatics research and services institute located in Hinxton, UK. It is part of the European Molecular Biology Laboratory and houses massive biological databases and bioinformatics software tools that are freely available to researchers. Key goals of EBI include building and maintaining biological databases, making data widely accessible, and conducting bioinformatics research to advance biology. EBI coordinates data collection and dissemination internationally and houses over 500 staff from diverse backgrounds.
European Molecular Biology Laboratory (EMBL)- European Bioinformatics Institu...ExternalEvents
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
Building the Database with International Isolates: European Molecular Biology Laboratory (EMBL)- European Bioinformatics Institute (EBI). Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management -23-25 May 2016, Rome, Italy.
This document provides information about the upcoming Biobanking 2010 conference, including details about speakers, workshops, and topics that will be discussed. Some key points:
- The conference will take place from September 27-29, 2010 in London and will focus on advancing international R&D through effective sample management and global biobanking harmonization.
- There will be 4 pre-conference workshops covering topics like biobanking technologies, optimizing operating efficiency with IT, establishing global biobanking networks, and building internal pharmaceutical biobanks.
- The main conference over 2 days will include sessions on biobanking within pharmaceutical companies, ensuring high sample quality, integrating biobanking into biomarker research, and building
This document discusses databases in bioinformatics. It begins by explaining that bioinformatics concerns the creation and maintenance of biological databases to allow researchers to access existing information and submit new entries. The aims of bioinformatics are to organize data, develop analysis tools, and use these tools to analyze data and interpret results in a biologically meaningful way. Several important biological databases are described, including nucleotide sequence databases like NCBI and protein sequence databases. GenBank is also discussed as the annotated collection of all publicly available DNA sequences. Biological databases make large datasets available to researchers and are important for biological research infrastructure.
British Library Datasets Programme
John Kaye - Lead Content Specialist datasets, British Library spoke on the British Library's Datasets programme and the DataCite project
2023-11-09 HealthRI Biobanking day_Amsterdam_Alain van Gool.pdfAlain van Gool
Examples of lessons learned in Omics-based biomarker studies from myself and colleagues in X-omics and EATRIS, for an audience of biobankers, researchers and diagnostic/clinical chemistry experts.
Slides for a keynote presentation to the EGI Technical Forum, 15th September 2010, Amsterdam on the construction challenges facing the LifeWatch research infrastructure.
FAIR Data Bridging from researcher data management to ELIXIR archives in the...Carole Goble
ISMB-ECCB 2021, NIH/ODSS Session, 27 July 2021
ELIXIR is the pan-national European Research Infrastructure for Life Science data, whose 23 national nodes and the EBI coordinate the development and long-term sustainability of domain public databases. FAIR services, policies and curation approaches aim to build a FAIR connected data ecosystem of trusted domain repositories, from ENA, HPA and EGA to specialised resources like CorkOakDB and PIPPA for plant phenotypes. But this is only one part of the data landscape and often the end of data’s journey. The nodes support research projects to operate “FAIR data first”, working with institutional and national platforms that are often generic or designed for project-based data management. We need to bridge between project-based and community-based, and support researchers across their whole RDM lifecycle, navigating the complexity this ecosystem. The ELIXIR-CONVERGE project and its flagship RDMkit toolkit (https://rdmkit.elixir-europe.org) aims to do just that.
This document discusses challenges in life sciences data management and services provided by ELIXIR to address these challenges. ELIXIR aims to facilitate life sciences research by building a sustainable infrastructure for biological data in Europe. It coordinates several nodes across member states that provide specialized data services. ELIXIR is also running pilot projects to test integration of services, including providing cloud access to reference data and distributed authentication and access to clinical archives. Future challenges include sustaining funding and scaling to handle exponentially growing data volumes.
BioVeL (Biodiversity Virtual e-Laboratory) is an e-laboratory that supports research on biodiversity using large amounts of data from cross-disciplinary sources.
A Global Commons for Scientific Data: Molecules and Wikidatapetermurrayrust
This document summarizes Peter Murray-Rust's work on developing software to extract structured data and information from scientific documents. It discusses tools to extract data from text, tables, images, computational logs, and more. It provides examples of extracting chemical information, disease and species data, and phylogenetic trees from figures. The goal is to liberate scientific data locked up in unstructured documents to enable new discoveries.
This document discusses the growing issue of large quantities of data from scientific research and simulations. It notes that data volumes are doubling every 9 months for genomic sequencing and that various scientific projects are now generating petabytes and exabytes of data. Current solutions for data management and analysis are often ad-hoc and inadequate for small and medium scale research. The document advocates for a national research cyberinfrastructure strategy in Canada that could provide standardized services and leverage partnerships with international organizations and commercial cloud providers to support scientists in dealing with large and complex research data. It raises questions about leadership and roles for universities, research organizations, and government in developing solutions.
This document discusses the challenges of interdisciplinarity and managing large amounts of biological data. It notes that while challenges seem easy from the perspective of one's own discipline, knowledge from other disciplines is needed. It then lists the names and affiliations of members of the "Dutch Team" working on issues related to biological data integration and management.
II-SDV 2012 From (Text) Mining to Models: Applying Large-Scale Text Mining on...Dr. Haxel Consult
The document discusses applying large-scale text mining techniques to patents and medical records. It describes Fraunhofer SCAI's research in text mining, disease modeling, and high performance computing. Their work includes developing technologies using HPC for high-throughput information extraction from knowledge sources and applying these techniques to tasks like automatic patent structuring and modeling neurodegenerative diseases.
ELIXIR aims to establish a pan-European infrastructure for biological information to support life sciences research. It will do this by coordinating nodes that provide services and resources, establishing standards, and closing skills gaps. Key challenges include sustaining data and services, ensuring interoperability, and dealing with increasingly large datasets. ELIXIR is working on pilots and task forces to address issues like cloud computing, storage, authentication and authorization.
Increasing demand and the use of high-quality samples, data and services place biobanks at the center of basic and applied research. The BBMRI-ERIC Quality Management Service (BBMRI.QM) is designed to help biobanks and researchers meet the highest quality standards for their research and meet the needs of their clients. This webinar will give you an insight into the service portfolio of BBMRI.QM and an overview of relevant European and international standards useful for research on human specimens.
CORBEL (http://www.corbel-project.eu) is an initiative of eleven new biological and medical research infrastructures (BMS RIs), which together will create a platform for harmonised user access to biological and medical technologies, biological samples and data services required by cutting-edge biomedical research. CORBEL will boost the efficiency, productivity and impact of European biomedical research.
This webinar took place on 6th December 2018 and is part of the CORBEL webinar series. A recording of the webinar is available through the CORBEL website:
https://www.corbel-project.eu/webinars/bbmri-eric-quality-management-services.html
For previous and upcoming CORBEL webinars see:
http://www.corbel-project.eu/webinars
ELIXIR is a European research infrastructure for biological information that aims to support life science research. It brings together major bioinformatics providers and is supported by 17 EU member states. ELIXIR works to safeguard biological data and build sustainable data services. It establishes a distributed infrastructure to handle the large growth of data and provides tools, services, and platforms to facilitate access and analysis of data. ELIXIR also develops standards and provides training to support computational biology. Key activities include establishing national nodes, technical task forces, and pilot projects in areas like cloud resources, data transfer, and linking distributed databases.
This talk was part of the 2020 Disease Map Modeling Community meeting, covering the steps towards publishing reproducible simulation studies (based on a reused model). Links to different COMBINE guidelines, tutorials and efforts. Grants: European Commission: EOSCsecretariat.eu - EOSCsecretariat.eu (831644)
Developing an Efficient Infrastruture, Standards and Data-Flow for MetabolomicsChristoph Steinbeck
The document discusses the development of efficient infrastructure, standards, and data flow for metabolomics. It describes the European Bioinformatics Institute (EBI) and its role in archiving, classifying, analyzing, and sharing metabolomics data through databases like MetaboLights. MetaboLights has experienced rapid data growth and is now the recommended repository for several journals. Efforts are underway to establish global standards and facilitate data exchange through initiatives like COSMOS and MetabolomeXchange. The document outlines plans to build out reference metabolomes and enable large-scale computing with medical metabolomics data.
The document summarizes progress made in DNA barcoding since the 2009 conference in Mexico City, including increased participation from non-academic sectors, acceleration of plant barcoding studies, adoption of barcoding standards by government agencies, expanded applications of barcoding, and increased data sharing through projects mining tissue from major collections. It notes barcoding is near a tipping point but faces challenges around scaling up efforts to build a comprehensive reference library, including engaging more collections and fieldwork with taxonomy support.
Aopting and adapting SeaDataNet services for EMODnet ChemistryEUDAT
The document summarizes how EMODnet Chemistry is adopting and adapting services from SeaDataNet to unlock fragmented marine chemistry data across Europe. Key points include:
- EMODnet Chemistry aggregates chemistry data from over 100 organizations across 27 countries to produce pan-European data products on topics like eutrophication, ocean acidification, and contaminants.
- It is using SeaDataNet standards for metadata, vocabularies, data formats, and tools to allow discovery, access, and visualization of harmonized chemistry data.
- Services being adopted include the CDI interface, ODV software, DIVA maps, and the Ocean Browser. New vocabularies are also being developed for EMODnet Chemistry.
This document discusses the use of linked data in industry. It provides examples of how the BBC, Volkswagen, and various government agencies are publishing open data using linked data approaches. It also discusses the potential for linked data in life sciences and healthcare, including a translational medicine platform for Alzheimer's disease. Semantic web projects in these domains aim to integrate data from distributed sources to answer complex queries. The challenges of big data in genomics are also mentioned, as well as the role of "data marketplaces" and platforms that enable access and integration of diverse biomedical datasets.
Perspectives on Collaborative Research Environments offered by D4ScienceFAO
Slides presented at the "4th Session of the IODE Group of Experts on Biological and Chemical Data Management and Exchange Practices (GE-BICH-IV)" which took place on 27-30 January 2009 in Oostende, Belgium
More information at: http://d4science.eu/node/173
The document announces the Personalised Medicine Conference 2014 to be held in Tallinn, Estonia. The conference will include workshops and presentations on topics related to personalized, individualized, and stratified medicine approaches using systems biology, genomics, and big data. Attendees will gain perspectives on personalized medicine from scientists, global alliances, different countries, healthcare professionals, and others.
More Related Content
Similar to Biobanks a cornerstone of Research Infrastructure
2023-11-09 HealthRI Biobanking day_Amsterdam_Alain van Gool.pdfAlain van Gool
Examples of lessons learned in Omics-based biomarker studies from myself and colleagues in X-omics and EATRIS, for an audience of biobankers, researchers and diagnostic/clinical chemistry experts.
Slides for a keynote presentation to the EGI Technical Forum, 15th September 2010, Amsterdam on the construction challenges facing the LifeWatch research infrastructure.
FAIR Data Bridging from researcher data management to ELIXIR archives in the...Carole Goble
ISMB-ECCB 2021, NIH/ODSS Session, 27 July 2021
ELIXIR is the pan-national European Research Infrastructure for Life Science data, whose 23 national nodes and the EBI coordinate the development and long-term sustainability of domain public databases. FAIR services, policies and curation approaches aim to build a FAIR connected data ecosystem of trusted domain repositories, from ENA, HPA and EGA to specialised resources like CorkOakDB and PIPPA for plant phenotypes. But this is only one part of the data landscape and often the end of data’s journey. The nodes support research projects to operate “FAIR data first”, working with institutional and national platforms that are often generic or designed for project-based data management. We need to bridge between project-based and community-based, and support researchers across their whole RDM lifecycle, navigating the complexity this ecosystem. The ELIXIR-CONVERGE project and its flagship RDMkit toolkit (https://rdmkit.elixir-europe.org) aims to do just that.
This document discusses challenges in life sciences data management and services provided by ELIXIR to address these challenges. ELIXIR aims to facilitate life sciences research by building a sustainable infrastructure for biological data in Europe. It coordinates several nodes across member states that provide specialized data services. ELIXIR is also running pilot projects to test integration of services, including providing cloud access to reference data and distributed authentication and access to clinical archives. Future challenges include sustaining funding and scaling to handle exponentially growing data volumes.
BioVeL (Biodiversity Virtual e-Laboratory) is an e-laboratory that supports research on biodiversity using large amounts of data from cross-disciplinary sources.
A Global Commons for Scientific Data: Molecules and Wikidatapetermurrayrust
This document summarizes Peter Murray-Rust's work on developing software to extract structured data and information from scientific documents. It discusses tools to extract data from text, tables, images, computational logs, and more. It provides examples of extracting chemical information, disease and species data, and phylogenetic trees from figures. The goal is to liberate scientific data locked up in unstructured documents to enable new discoveries.
This document discusses the growing issue of large quantities of data from scientific research and simulations. It notes that data volumes are doubling every 9 months for genomic sequencing and that various scientific projects are now generating petabytes and exabytes of data. Current solutions for data management and analysis are often ad-hoc and inadequate for small and medium scale research. The document advocates for a national research cyberinfrastructure strategy in Canada that could provide standardized services and leverage partnerships with international organizations and commercial cloud providers to support scientists in dealing with large and complex research data. It raises questions about leadership and roles for universities, research organizations, and government in developing solutions.
This document discusses the challenges of interdisciplinarity and managing large amounts of biological data. It notes that while challenges seem easy from the perspective of one's own discipline, knowledge from other disciplines is needed. It then lists the names and affiliations of members of the "Dutch Team" working on issues related to biological data integration and management.
II-SDV 2012 From (Text) Mining to Models: Applying Large-Scale Text Mining on...Dr. Haxel Consult
The document discusses applying large-scale text mining techniques to patents and medical records. It describes Fraunhofer SCAI's research in text mining, disease modeling, and high performance computing. Their work includes developing technologies using HPC for high-throughput information extraction from knowledge sources and applying these techniques to tasks like automatic patent structuring and modeling neurodegenerative diseases.
ELIXIR aims to establish a pan-European infrastructure for biological information to support life sciences research. It will do this by coordinating nodes that provide services and resources, establishing standards, and closing skills gaps. Key challenges include sustaining data and services, ensuring interoperability, and dealing with increasingly large datasets. ELIXIR is working on pilots and task forces to address issues like cloud computing, storage, authentication and authorization.
Increasing demand and the use of high-quality samples, data and services place biobanks at the center of basic and applied research. The BBMRI-ERIC Quality Management Service (BBMRI.QM) is designed to help biobanks and researchers meet the highest quality standards for their research and meet the needs of their clients. This webinar will give you an insight into the service portfolio of BBMRI.QM and an overview of relevant European and international standards useful for research on human specimens.
CORBEL (http://www.corbel-project.eu) is an initiative of eleven new biological and medical research infrastructures (BMS RIs), which together will create a platform for harmonised user access to biological and medical technologies, biological samples and data services required by cutting-edge biomedical research. CORBEL will boost the efficiency, productivity and impact of European biomedical research.
This webinar took place on 6th December 2018 and is part of the CORBEL webinar series. A recording of the webinar is available through the CORBEL website:
https://www.corbel-project.eu/webinars/bbmri-eric-quality-management-services.html
For previous and upcoming CORBEL webinars see:
http://www.corbel-project.eu/webinars
ELIXIR is a European research infrastructure for biological information that aims to support life science research. It brings together major bioinformatics providers and is supported by 17 EU member states. ELIXIR works to safeguard biological data and build sustainable data services. It establishes a distributed infrastructure to handle the large growth of data and provides tools, services, and platforms to facilitate access and analysis of data. ELIXIR also develops standards and provides training to support computational biology. Key activities include establishing national nodes, technical task forces, and pilot projects in areas like cloud resources, data transfer, and linking distributed databases.
This talk was part of the 2020 Disease Map Modeling Community meeting, covering the steps towards publishing reproducible simulation studies (based on a reused model). Links to different COMBINE guidelines, tutorials and efforts. Grants: European Commission: EOSCsecretariat.eu - EOSCsecretariat.eu (831644)
Developing an Efficient Infrastruture, Standards and Data-Flow for MetabolomicsChristoph Steinbeck
The document discusses the development of efficient infrastructure, standards, and data flow for metabolomics. It describes the European Bioinformatics Institute (EBI) and its role in archiving, classifying, analyzing, and sharing metabolomics data through databases like MetaboLights. MetaboLights has experienced rapid data growth and is now the recommended repository for several journals. Efforts are underway to establish global standards and facilitate data exchange through initiatives like COSMOS and MetabolomeXchange. The document outlines plans to build out reference metabolomes and enable large-scale computing with medical metabolomics data.
The document summarizes progress made in DNA barcoding since the 2009 conference in Mexico City, including increased participation from non-academic sectors, acceleration of plant barcoding studies, adoption of barcoding standards by government agencies, expanded applications of barcoding, and increased data sharing through projects mining tissue from major collections. It notes barcoding is near a tipping point but faces challenges around scaling up efforts to build a comprehensive reference library, including engaging more collections and fieldwork with taxonomy support.
Aopting and adapting SeaDataNet services for EMODnet ChemistryEUDAT
The document summarizes how EMODnet Chemistry is adopting and adapting services from SeaDataNet to unlock fragmented marine chemistry data across Europe. Key points include:
- EMODnet Chemistry aggregates chemistry data from over 100 organizations across 27 countries to produce pan-European data products on topics like eutrophication, ocean acidification, and contaminants.
- It is using SeaDataNet standards for metadata, vocabularies, data formats, and tools to allow discovery, access, and visualization of harmonized chemistry data.
- Services being adopted include the CDI interface, ODV software, DIVA maps, and the Ocean Browser. New vocabularies are also being developed for EMODnet Chemistry.
This document discusses the use of linked data in industry. It provides examples of how the BBC, Volkswagen, and various government agencies are publishing open data using linked data approaches. It also discusses the potential for linked data in life sciences and healthcare, including a translational medicine platform for Alzheimer's disease. Semantic web projects in these domains aim to integrate data from distributed sources to answer complex queries. The challenges of big data in genomics are also mentioned, as well as the role of "data marketplaces" and platforms that enable access and integration of diverse biomedical datasets.
Perspectives on Collaborative Research Environments offered by D4ScienceFAO
Slides presented at the "4th Session of the IODE Group of Experts on Biological and Chemical Data Management and Exchange Practices (GE-BICH-IV)" which took place on 27-30 January 2009 in Oostende, Belgium
More information at: http://d4science.eu/node/173
Similar to Biobanks a cornerstone of Research Infrastructure (20)
The document announces the Personalised Medicine Conference 2014 to be held in Tallinn, Estonia. The conference will include workshops and presentations on topics related to personalized, individualized, and stratified medicine approaches using systems biology, genomics, and big data. Attendees will gain perspectives on personalized medicine from scientists, global alliances, different countries, healthcare professionals, and others.
The document discusses the work of the Luxembourg Centre for Systems Biomedicine (LCSB), an interdisciplinary research center that studies neurodegenerative diseases. The LCSB takes a systems approach and brings together experts from various fields including biology, computer science, engineering, and clinical science. Successful interdisciplinary work requires teamwork, proximity between researchers, increasing communication, and sharing credit. The document also discusses community-driven disease mapping projects and efforts to apply concepts from ecology to medicine, such as identifying early warning signals of disease.
The document discusses the formation and goals of the Global Alliance for Genomics and Health. It was started in 2013 to facilitate international sharing of genomic and clinical data. Its goals are to establish common frameworks for data sharing, catalyze specific data sharing projects, and demonstrate the value of aggregating data from many sources. It currently has over 200 partner organizations from 30 countries. Working groups are advancing priorities around regulatory issues, data standards, security, and clinical implementation. The alliance aims to create a growing, sustainable network that continuously improves understanding of human health through large-scale data sharing and analysis.
This document summarizes discussions from the 6th Genomic Medicine Colloquium hosted by the National Human Genome Research Institute. The colloquium brought together 50 international genomic medicine leaders from 25 countries to discuss opportunities for collaboration. Key areas of discussion included establishing standards for genomic data storage, implementing global pharmacogenomic screening programs, developing genomic medicine policy, and creating an international genomic medicine collaborative.
This document outlines a vision for the future of healthcare in the Netherlands created by a taskforce of young healthcare professionals including doctors, pharmacists, and other specialists. They envision a system in 2025 that is more focused on prevention, coaching, and collaboration between providers. Key aspects of their vision include healthcare that is personalized and located closer to home, with general practitioners as the primary providers and specialists handling complex cases. Healthcare will be delivered through greater digitalization and self-management tools. Funding will reward quality over volume, and the system will emphasize flexibility, lifelong learning, and a coaching approach that prioritizes patients' expectations and shared decision making.
Johanna Adami is the director and head of health at VINNOVA, Sweden's innovation agency. She discusses Sweden's national innovation strategy and VINNOVA's role in funding research and innovation. VINNOVA aims to address grand challenges like health, the environment, and an aging population through collaborative projects bringing together researchers, industries, and other stakeholders both within Sweden and internationally. VINNOVA's health programs support personalized medicine, life sciences, and reforming healthcare to be more innovation-focused. The future roadmap involves stronger public-private partnerships and providing evidence of innovation outcomes.
1. Graham Love discusses the development of personalized medicine in Ireland from the perspective of the Health Research Board.
2. While some personalized cancer care exists, moving towards personalized medicine research requires large-scale sequencing efforts and clinical trials to validate biomarkers and treatments.
3. For personalized medicine to become a true revolution, there needs to be greater efforts to educate decision-makers and the general public about what personalized medicine is and its potential benefits.
The document discusses the Basque Biobank in Spain, which collects human samples and medical information to enable personalized medicine and research. It serves over 300 clients annually. The Biobank aims to improve accessibility to samples and data through research and development initiatives. This includes developing a private cloud to store sample data and images, and recruiting partners to help with medical database mining and search capabilities. The ultimate goal is to facilitate research by allowing accessible searches across multiple biobanks.
Ruud Simons, a program manager from Nictiz in the Netherlands, gave a presentation on personalized medicine from the perspective of health insurers. He discussed several key points:
1) Achieving the "triple aim" of improving patient experience, population health, and reducing costs through practices like benchmarking expensive drugs and treatments tailored to individuals.
2) The importance of standards, interoperability, and international cooperation to connect initiatives and share best practices.
3) The role of patient registries and empowerment in combining data to support clinical decision making and providing patients access to their own health information.
The document discusses the UK's commitment to becoming a global leader in stratified medicine. Some key points:
- Stratified medicine aims to optimize treatment for individual patients rather than broad disease groups, improving outcomes and unlocking business opportunities.
- The UK offers world-leading research expertise, data and infrastructure like large patient datasets and biobanks to help businesses develop and deliver stratified medicine products.
- There are significant market opportunities for stratified medicine and companion diagnostics globally. The UK can help businesses prepare for and access this growing market.
EuroBioForum 2013 - Day 1 | Wolfgang EberleEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# NATIONAL PERSPECTIVES #
Belgium
Working across disciplines for our health benefit - From successful strategies for biotech and nanotech to Nanotech for Health in Flanders
Wolfgang Eberle
Funded Program Manager Life Science Technologies Imec
=======================================
http://www.eurobioforum.eu
EuroBioForum 2013 - Day 2 | Rachael RitchieEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# REGIONAL PERSPECTIVES #
Genome British Colombia, Canada:
Regional Perspectives on Personalized Medicine in British Columbia, Canada
Dr Rachael Ritchie
Director Business Development Genome British Colombia
=======================================
http://www.eurobioforum.eu
The heart of life sciences full reportEuroBioForum
This document provides an overview of why Denmark is an attractive location for healthcare research and business activities. It begins with a top 10 list of reasons for choosing Denmark for pharmaceutical research, medical devices businesses, and investing in the Danish eHealth industry. The document then covers several topics: the strong Danish healthcare industry including pharmaceutical, biotech, medical devices, and eHealth sectors; the robust Danish healthcare system and culture of collaboration; the tradition of and support for clinical trials; world-class Danish research areas and institutions; and the business-friendly environment in Denmark. Overall, the document promotes Denmark as a unique laboratory for healthcare innovation with its strong industries, regulatory frameworks, research infrastructure, and business conditions.
EuroBioForum 2013 - Day 2 | Jami TaylorEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# KEYNOTE PRESENTATION #
Personalised medicine education & training
Macro challenges and the path forward
Jami Taylor
Senior Director, Global Access Policy at Janssen, the Pharmaceutical Companies of Johnson & Johnson
Vice-chair of the Education Committee of EPEMED
=======================================
http://www.eurobioforum.eu
EuroBioForum 2013 - Day 2 | Frank MolinaEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# REGIONAL PERSPECTIVES #
EuroBioMed, France:
Private-public collaborations to boost open innovation
Dr Franck Molina
President of EDCA, Chair of diagnosis group of Eurobiomed
Director of Sysdiag
=======================================
http://www.eurobioforum.eu
EuroBioForum 2013 - Day 2 | Mark PoznanskyEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# REGIONAL PERSPECTIVES #
Ontario Genomics Institute, Canada:
Innovative Research, Innovative Translation
Dr Mark Poznansky
President and CEO Ontario Genomics Institute
=======================================
http://www.eurobioforum.eu
EuroBioForum 2013 - Day 2 | Marc LapageEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# REGIONAL PERSPECTIVES #
Genome Quebec, Canada:
Personalised medicine – Reaching the patient?
Marc LePage
President and CEO Genome Quebec
=======================================
http://www.eurobioforum.eu
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# REGIONAL PERSPECTIVES #
Rotterdam Delta, The Netherlands:
What’s keeping medicine from becoming personalised?
Dr Menno Kok,
Advisor Research Strategies Erasmus MC and sector manager Medical Delta
=======================================
http://www.eurobioforum.eu
EuroBioForum 2013 - Day 2 | Alberto BaldiEuroBioForum
The document discusses the bioPmed cluster initiative in Italy's Piedmont region, which brings together companies, universities, and research centers working in life sciences and medical technologies. The initiative takes a strategic approach to personalized medicine focusing on converging multiple technologies. This includes areas like biotech, medical devices, ICT, and others. The goal is to develop innovative solutions for healthcare by combining diverse technological expertise. BioPmed has over 80 core members and works internationally with other clusters through partnerships and shared projects.
"Frontline Battles with DDoS: Best practices and Lessons Learned", Igor IvaniukFwdays
At this talk we will discuss DDoS protection tools and best practices, discuss network architectures and what AWS has to offer. Also, we will look into one of the largest DDoS attacks on Ukrainian infrastructure that happened in February 2022. We'll see, what techniques helped to keep the web resources available for Ukrainians and how AWS improved DDoS protection for all customers based on Ukraine experience
LF Energy Webinar: Carbon Data Specifications: Mechanisms to Improve Data Acc...DanBrown980551
This LF Energy webinar took place June 20, 2024. It featured:
-Alex Thornton, LF Energy
-Hallie Cramer, Google
-Daniel Roesler, UtilityAPI
-Henry Richardson, WattTime
In response to the urgency and scale required to effectively address climate change, open source solutions offer significant potential for driving innovation and progress. Currently, there is a growing demand for standardization and interoperability in energy data and modeling. Open source standards and specifications within the energy sector can also alleviate challenges associated with data fragmentation, transparency, and accessibility. At the same time, it is crucial to consider privacy and security concerns throughout the development of open source platforms.
This webinar will delve into the motivations behind establishing LF Energy’s Carbon Data Specification Consortium. It will provide an overview of the draft specifications and the ongoing progress made by the respective working groups.
Three primary specifications will be discussed:
-Discovery and client registration, emphasizing transparent processes and secure and private access
-Customer data, centering around customer tariffs, bills, energy usage, and full consumption disclosure
-Power systems data, focusing on grid data, inclusive of transmission and distribution networks, generation, intergrid power flows, and market settlement data
Discover top-tier mobile app development services, offering innovative solutions for iOS and Android. Enhance your business with custom, user-friendly mobile applications.
Must Know Postgres Extension for DBA and Developer during MigrationMydbops
Mydbops Opensource Database Meetup 16
Topic: Must-Know PostgreSQL Extensions for Developers and DBAs During Migration
Speaker: Deepak Mahto, Founder of DataCloudGaze Consulting
Date & Time: 8th June | 10 AM - 1 PM IST
Venue: Bangalore International Centre, Bangalore
Abstract: Discover how PostgreSQL extensions can be your secret weapon! This talk explores how key extensions enhance database capabilities and streamline the migration process for users moving from other relational databases like Oracle.
Key Takeaways:
* Learn about crucial extensions like oracle_fdw, pgtt, and pg_audit that ease migration complexities.
* Gain valuable strategies for implementing these extensions in PostgreSQL to achieve license freedom.
* Discover how these key extensions can empower both developers and DBAs during the migration process.
* Don't miss this chance to gain practical knowledge from an industry expert and stay updated on the latest open-source database trends.
Mydbops Managed Services specializes in taking the pain out of database management while optimizing performance. Since 2015, we have been providing top-notch support and assistance for the top three open-source databases: MySQL, MongoDB, and PostgreSQL.
Our team offers a wide range of services, including assistance, support, consulting, 24/7 operations, and expertise in all relevant technologies. We help organizations improve their database's performance, scalability, efficiency, and availability.
Contact us: info@mydbops.com
Visit: https://www.mydbops.com/
Follow us on LinkedIn: https://in.linkedin.com/company/mydbops
For more details and updates, please follow up the below links.
Meetup Page : https://www.meetup.com/mydbops-databa...
Twitter: https://twitter.com/mydbopsofficial
Blogs: https://www.mydbops.com/blog/
Facebook(Meta): https://www.facebook.com/mydbops/
How to Interpret Trends in the Kalyan Rajdhani Mix Chart.pdfChart Kalyan
A Mix Chart displays historical data of numbers in a graphical or tabular form. The Kalyan Rajdhani Mix Chart specifically shows the results of a sequence of numbers over different periods.
Introduction of Cybersecurity with OSS at Code Europe 2024Hiroshi SHIBATA
I develop the Ruby programming language, RubyGems, and Bundler, which are package managers for Ruby. Today, I will introduce how to enhance the security of your application using open-source software (OSS) examples from Ruby and RubyGems.
The first topic is CVE (Common Vulnerabilities and Exposures). I have published CVEs many times. But what exactly is a CVE? I'll provide a basic understanding of CVEs and explain how to detect and handle vulnerabilities in OSS.
Next, let's discuss package managers. Package managers play a critical role in the OSS ecosystem. I'll explain how to manage library dependencies in your application.
I'll share insights into how the Ruby and RubyGems core team works to keep our ecosystem safe. By the end of this talk, you'll have a better understanding of how to safeguard your code.
5th LF Energy Power Grid Model Meet-up SlidesDanBrown980551
5th Power Grid Model Meet-up
It is with great pleasure that we extend to you an invitation to the 5th Power Grid Model Meet-up, scheduled for 6th June 2024. This event will adopt a hybrid format, allowing participants to join us either through an online Mircosoft Teams session or in person at TU/e located at Den Dolech 2, Eindhoven, Netherlands. The meet-up will be hosted by Eindhoven University of Technology (TU/e), a research university specializing in engineering science & technology.
Power Grid Model
The global energy transition is placing new and unprecedented demands on Distribution System Operators (DSOs). Alongside upgrades to grid capacity, processes such as digitization, capacity optimization, and congestion management are becoming vital for delivering reliable services.
Power Grid Model is an open source project from Linux Foundation Energy and provides a calculation engine that is increasingly essential for DSOs. It offers a standards-based foundation enabling real-time power systems analysis, simulations of electrical power grids, and sophisticated what-if analysis. In addition, it enables in-depth studies and analysis of the electrical power grid’s behavior and performance. This comprehensive model incorporates essential factors such as power generation capacity, electrical losses, voltage levels, power flows, and system stability.
Power Grid Model is currently being applied in a wide variety of use cases, including grid planning, expansion, reliability, and congestion studies. It can also help in analyzing the impact of renewable energy integration, assessing the effects of disturbances or faults, and developing strategies for grid control and optimization.
What to expect
For the upcoming meetup we are organizing, we have an exciting lineup of activities planned:
-Insightful presentations covering two practical applications of the Power Grid Model.
-An update on the latest advancements in Power Grid -Model technology during the first and second quarters of 2024.
-An interactive brainstorming session to discuss and propose new feature requests.
-An opportunity to connect with fellow Power Grid Model enthusiasts and users.
Northern Engraving | Nameplate Manufacturing Process - 2024Northern Engraving
Manufacturing custom quality metal nameplates and badges involves several standard operations. Processes include sheet prep, lithography, screening, coating, punch press and inspection. All decoration is completed in the flat sheet with adhesive and tooling operations following. The possibilities for creating unique durable nameplates are endless. How will you create your brand identity? We can help!
"Choosing proper type of scaling", Olena SyrotaFwdays
Imagine an IoT processing system that is already quite mature and production-ready and for which client coverage is growing and scaling and performance aspects are life and death questions. The system has Redis, MongoDB, and stream processing based on ksqldb. In this talk, firstly, we will analyze scaling approaches and then select the proper ones for our system.
Session 1 - Intro to Robotic Process Automation.pdfUiPathCommunity
👉 Check out our full 'Africa Series - Automation Student Developers (EN)' page to register for the full program:
https://bit.ly/Automation_Student_Kickstart
In this session, we shall introduce you to the world of automation, the UiPath Platform, and guide you on how to install and setup UiPath Studio on your Windows PC.
📕 Detailed agenda:
What is RPA? Benefits of RPA?
RPA Applications
The UiPath End-to-End Automation Platform
UiPath Studio CE Installation and Setup
💻 Extra training through UiPath Academy:
Introduction to Automation
UiPath Business Automation Platform
Explore automation development with UiPath Studio
👉 Register here for our upcoming Session 2 on June 20: Introduction to UiPath Studio Fundamentals: https://community.uipath.com/events/details/uipath-lagos-presents-session-2-introduction-to-uipath-studio-fundamentals/
Have you ever been confused by the myriad of choices offered by AWS for hosting a website or an API?
Lambda, Elastic Beanstalk, Lightsail, Amplify, S3 (and more!) can each host websites + APIs. But which one should we choose?
Which one is cheapest? Which one is fastest? Which one will scale to meet our needs?
Join me in this session as we dive into each AWS hosting service to determine which one is best for your scenario and explain why!
Essentials of Automations: Exploring Attributes & Automation ParametersSafe Software
Building automations in FME Flow can save time, money, and help businesses scale by eliminating data silos and providing data to stakeholders in real-time. One essential component to orchestrating complex automations is the use of attributes & automation parameters (both formerly known as “keys”). In fact, it’s unlikely you’ll ever build an Automation without using these components, but what exactly are they?
Attributes & automation parameters enable the automation author to pass data values from one automation component to the next. During this webinar, our FME Flow Specialists will cover leveraging the three types of these output attributes & parameters in FME Flow: Event, Custom, and Automation. As a bonus, they’ll also be making use of the Split-Merge Block functionality.
You’ll leave this webinar with a better understanding of how to maximize the potential of automations by making use of attributes & automation parameters, with the ultimate goal of setting your enterprise integration workflows up on autopilot.
What is an RPA CoE? Session 1 – CoE VisionDianaGray10
In the first session, we will review the organization's vision and how this has an impact on the COE Structure.
Topics covered:
• The role of a steering committee
• How do the organization’s priorities determine CoE Structure?
Speaker:
Chris Bolin, Senior Intelligent Automation Architect Anika Systems
Connector Corner: Seamlessly power UiPath Apps, GenAI with prebuilt connectorsDianaGray10
Join us to learn how UiPath Apps can directly and easily interact with prebuilt connectors via Integration Service--including Salesforce, ServiceNow, Open GenAI, and more.
The best part is you can achieve this without building a custom workflow! Say goodbye to the hassle of using separate automations to call APIs. By seamlessly integrating within App Studio, you can now easily streamline your workflow, while gaining direct access to our Connector Catalog of popular applications.
We’ll discuss and demo the benefits of UiPath Apps and connectors including:
Creating a compelling user experience for any software, without the limitations of APIs.
Accelerating the app creation process, saving time and effort
Enjoying high-performance CRUD (create, read, update, delete) operations, for
seamless data management.
Speakers:
Russell Alfeche, Technology Leader, RPA at qBotic and UiPath MVP
Charlie Greenberg, host
"$10 thousand per minute of downtime: architecture, queues, streaming and fin...Fwdays
Direct losses from downtime in 1 minute = $5-$10 thousand dollars. Reputation is priceless.
As part of the talk, we will consider the architectural strategies necessary for the development of highly loaded fintech solutions. We will focus on using queues and streaming to efficiently work and manage large amounts of data in real-time and to minimize latency.
We will focus special attention on the architectural patterns used in the design of the fintech system, microservices and event-driven architecture, which ensure scalability, fault tolerance, and consistency of the entire system.
"$10 thousand per minute of downtime: architecture, queues, streaming and fin...
Biobanks a cornerstone of Research Infrastructure
1. EuroBioForum
Is Europe ready for Personal Medicine?
18 April 2012, The Dominican Hotel, Brussels
Biobanks a cornerstone of Research
Infrastructure
Professor Jan-Eric Litton
Director BBMRI.se
3. Libraries of Flesh: The Sorry State of Human Tissue storage
Every year, billions of dollars’ worth of research into the genetic
underpinnings of autism, schizophrenia, diabetes, Alzheimer’s disease, and
other devastating disorders hinges on scientists’ ability to tap industrial
quantities of cells and tissue. But Compton found that while our technology
for decoding the inner workings of life is advancing dramatically, the
protocols for collecting and storing specimens of human flesh have barely
evolved in decades. At the same time, innovation in the field of biobanking
has stalled for lack of funding and interest. The science of bio-preservation is
still considered an arcane, musty specialty, more akin to taxidermy than
medicine. “You might have thought that doing the science would be the
biggest challenge of a massive undertaking like the Cancer Genome Atlas,”
Compton told me last fall. “But acquiring the biospecimens turned out to be
the hardest part, bar none. It’s the Wild West out there.”
8 maj 2012 3
4. Libraries of Flesh: The Sorry State of Human Tissue storage
One bank at a major university claimed to have more than 12,000 samples of glioblastoma
in its collection.
Only 18 of those were good enough to use.
The rate of unacceptable shipments from other institutions ran as high as 99 percent.
8 maj 2012 4
7. Connecting Biobanks -
leading design principals for BBMRI
The leading seven design principals during the work for the
presented scenarios, use cases and software architecture
are:
· Assuring confidentiality of donors
· Following a user centered approach and providing a
maximum support for researchers
· Use of up to date Web-Technologies
· Flexibility in terms of biobank content and schema handling
· Extensibility in terms of additional participants and adding
new data and information
· Efficiency in terms of query processing
· Low effort for biobanks to participate in federation
8 maj 2012 7
8. BBMRI PP 13 countries agreed on a
Minimal Dataset for Biobanks
Andrea Calabria, CNR-ITB (IT) Erkki Leego, UTARTU (EE)
Mario Caccamo, EMBL-EBI (UK) Jan-Eric Litton, KI (SE)
Claus Dabringer, UNI-KLU (AT) Fernando López, VITRO, SA (ES)
Johann Eder, UNI-KLU (AT) Ioannis Michalopoulos, BRFAA (GR)
Paul Flicek, EMBL-EBI (UK) Luciano Milanesi, CNR-ITB (IT)
Ruslan Fomkin, KI (SE) Juha Muilu, NPHI (FI)
Martin Fransson, KI (SE) Louis Rechaussat, INSERM (FR)
Hákon Gudbjartsson, deCODE (IS) Blandine Rimbault, INSERM (FR)
Andy Harris, UK Biobank (UK) Tore Risch, UU (SE)
Hans Hillege, UMCG (NL) Pedro Roiz, VITRO, SA (ES)
Maria Krestyaninova, EMBL-EBI (UK) Paolo Romano, IST (IT)
Klaus Kuhn, TUM (DE) Morris Swertz, UMCG (NL)
FP7, Grant Agreement Nr. 212111
9. Connecting Biobanks –
A simple example
User scenario 1: Get attributes for biobanks
Peter logs in to the BBMRI portal and goes to the search function.
He then first needs to choose one of the ontologies that are included in UMLS Metathesaurus:
a. Select ontology
ICD-10
He makes the following choices of input (by query statements or predefined scrollbars) for the set
"Attributes for biobanks":
b. Type of diagnosis | Using ICD-10
C50. //Note: non-specific code not used for diagnosis
c. Type of sample
tissue
d. Method of preservation
All
e. Data needed
Diagnosis information
Number of samples
Collections with at least 100 samples
8 maj 2012 9
10. Implemented metadata model for the BBMRI-
Demo prototype
During this phase eight accounts have been
released:
4 biobanks uploaded data (TU-Munich, MUG-
Biobank, Institute for Molecular Medicine
Finland, CRIP)
~15.000 cases already stored in database
The other account holders only had query-access-
rights (Vitrosoft, CRB-IST, Karolinska Institutet
Biobank, French National Cancer Institute)
8 maj 2012 10
13. BBMRI.se – a unified Swedish
infrastructure for biobanking
WP1 – Project management
WP2 & WP3 WP4 WP5 WP6 WP7 WP8
Collection: Analysis: IT Physical Ethics Financing
Input Output Facility
Coordinate & Optimize Enforce a Create an Provide Ensure long-
harmonize interface to unifying efficient national term
sample / data analysis national IT national, expertise and financing
collection resources platform large scale forum to
from sample address
populations handling ethical
& hospitals platform issues
Nitrogen tanks (-190° C)
Central storage stores ~100 million tubes
and withdrawal = “hard drive”
Distributed sample
handling at local biobanks Automatic repicking unit
and hospitals at -80° C. Fast
withdrawal of tubes =
“processor and RAM
memory”
8 maj 2012 13
14. Nordic BBMRI
Inventory of all Nordic biobanks
Pilot study: Colon cancer
8 maj 2012 14
23. Biobank MeSH profile
Database: MEDLINE:
------------------------------------------------------------------------------
1 exp Biological Specimen Banks/
2 exp Tissue Preservation/
3 gene library/
4 specimen handling/ or exp preservation, biological/ or "tissue and organ harvestin
5 databases, genetic/ and exp dna/
6 databases, nucleic acid/
7 1 or 2 or 3 or 4 or 5 or 6
8 limit 7 to humans
9 8 not exp diagnostic imaging/
10 9 not exp bacteria/
11 exp transplantation/ or tr.fs.
12 10 not 11
13 (biorepositor* or biobank* or bio-bank*).mp.
14 7 and (lj or es or st or og).fs.
15 12 or 13 or 14
8 maj 2012 23
28. Individual Collective
interest interests
conflict
between
Privacy Access
Balance
8 maj 2012 28
29. Border P: Sequence sharing. Nature 470:169-170, 2011
“No amount of data will be useful if you can’t
interpret what they mean. We are reaching the
point at which the cost of interpreting genome
information will exceed the cost of generating it, so
the challenge ahead will be to make more sense of
the data we already have. We will also have to
answer the question of whether genome data are
personal, in that they are paid for and controlled by
individuals, or whether such data are medical,
being funded by and accessible to health-care
systems.”
8 maj 2012 29
30. We are ready to connect Biobanks in Europe
8 maj 2012 30